Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nolan

Showing results (371-380 of 386) with videos related to

Pageof 39
Sort By:
JCI Insight|January 11, 2022
Functional characterization of the biogenic amine transporters on human macrophagesPhillip M Mackie, Adithya Gopinath, Dominic M Montas, et al.
Kidney International|December 4, 2018
Generation of renal Epo-producing cell lines by conditional gene tagging reveals rapid HIF-2 driven Epo kinetics, cell autonomous feedback regulation, and a telocyte phenotypeFaik Imeri, Karen A Nolan, Andreas M Bapst, et al.
Internal Medicine Journal|October 27, 2023
Impact of cystic fibrosis multidisciplinary virtual clinics on patient experience, time commitments and costsJody M Bell, Tiffany J Dwyer, Michelle Cunich, et al.
The American Psychologist|June 8, 2026
International Competences for Undergraduate Psychology (ICUP): A constructive shift for psychology?Susan A Nolan, Jacquelyn Cranney, Susanne Narciss, et al.
International Journal of Psychology : Journal International De Psychologie|June 10, 2025
Collaborative Processes in the Development of the International Competences for Undergraduate Psychology (ICUP) ModelJacquelyn Cranney, Susan A Nolan, Remo Job, et al.
Life Sciences|January 1, 1996
Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonistD L Williams, K L Murphy, N A Nolan, et al.
Scientific Reports|August 18, 2016
REST is a hypoxia-responsive transcriptional repressorMiguel A S Cavadas, Marion Mesnieres, Bianca Crifo, et al.
Annals of Neurology|August 28, 2023
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT TrialElizabeth Martina Bebin, Jurriaan M Peters, Brenda E Porter, et al.
Anesthesiology and Perioperative Science|January 22, 2026
Neurophysiological differences between dexmedetomidine sedation and natural sleep across the rodent lifespan: implications for aging and perioperative brain healthMorgan J Siegmann, Daniel P Zachs, Jonathan D Kenny, et al.
Pediatric Neurology|August 14, 2024
Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) TrialLaura S Farach, Melissa A Richard, Aynara C Wulsin, et al.
Pageof 39

Showing results (371-380 of 386) with videos related to

Sort By:
Pageof 39
JCI Insight|January 11, 2022
Functional characterization of the biogenic amine transporters on human macrophagesPhillip M Mackie, Adithya Gopinath, Dominic M Montas, et al.
Kidney International|December 4, 2018
Generation of renal Epo-producing cell lines by conditional gene tagging reveals rapid HIF-2 driven Epo kinetics, cell autonomous feedback regulation, and a telocyte phenotypeFaik Imeri, Karen A Nolan, Andreas M Bapst, et al.
Internal Medicine Journal|October 27, 2023
Impact of cystic fibrosis multidisciplinary virtual clinics on patient experience, time commitments and costsJody M Bell, Tiffany J Dwyer, Michelle Cunich, et al.
The American Psychologist|June 8, 2026
International Competences for Undergraduate Psychology (ICUP): A constructive shift for psychology?Susan A Nolan, Jacquelyn Cranney, Susanne Narciss, et al.
International Journal of Psychology : Journal International De Psychologie|June 10, 2025
Collaborative Processes in the Development of the International Competences for Undergraduate Psychology (ICUP) ModelJacquelyn Cranney, Susan A Nolan, Remo Job, et al.
Life Sciences|January 1, 1996
Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonistD L Williams, K L Murphy, N A Nolan, et al.
Scientific Reports|August 18, 2016
REST is a hypoxia-responsive transcriptional repressorMiguel A S Cavadas, Marion Mesnieres, Bianca Crifo, et al.
Annals of Neurology|August 28, 2023
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT TrialElizabeth Martina Bebin, Jurriaan M Peters, Brenda E Porter, et al.
Anesthesiology and Perioperative Science|January 22, 2026
Neurophysiological differences between dexmedetomidine sedation and natural sleep across the rodent lifespan: implications for aging and perioperative brain healthMorgan J Siegmann, Daniel P Zachs, Jonathan D Kenny, et al.
Pediatric Neurology|August 14, 2024
Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) TrialLaura S Farach, Melissa A Richard, Aynara C Wulsin, et al.
Pageof 39